Scholarlink

Background and aims <p>Schwannomas are rarely seen in the upper gastrointestinal tract. The diagnostic and therapeutic strategies for digestive schwannomas have not been studied comprehensively enough. We aimed to investigate the clinical and endoscopic features of upper gastrointestinal schwannomas (UGIS). Additionally, the safety and efficacy of endoscopic resection (ER) for UGIS were evaluated.</p> Methods <p>From March 2013 to June 2025, the patients who underwent ER for UGIS in our center were enrolled. Clinical characteristics, endoscopic ultrasound (EUS) and histopathological results were analyzed retrospectively. The rate of en-bloc resection, complete resection and recurrence were used to evaluate ER outcomes.</p> Results <p>In total, 54 patients (36 females, 18 males) were enrolled with a mean age of 51.6 ± 12.8&#xa0;years. The mean tumor size was 21.7&#xa0;mm (SD: 10.6&#xa0;mm). Thirty-nine lesions were located at the gastric body, seven in the gastric antrum, two in the gastric angle and six in the esophagus. Twenty-two patients suffered from digestive symptoms including abdominal pain (11/54, 20.4%), abdominal distention (9/54, 16.7%) and acid reflux (2/54, 3.7%). The endoscopic morphology of UGIS was diverse with a predominance of hemisphere-type (32/54, 59.3%). Under EUS, most tumors presented as hypoechoic lesions (50/54, 92.6%). The rate of en-bloc and complete resection was 88.9% and no local residue or recurrence was observed during a following-up duration of 56.0 ± 39.7&#xa0;months. Histopathological results revealed all tumors showed positive for S-100. For gastric schwannomas, the occurrence of digestive symptoms was more common in those tumors exhibiting extraluminal growing pattern (extraluminal vs. intraluminal = 14/23 vs. 7/25, <i>P</i> = 0.022).</p> Conclusions <p>UGIS demonstrates characteristic appearance under EUS. Confirmed diagnosis of UGIS depends on immunohistochemistry tests. The occurrence of clinical symptoms in gastric schwannomas might be associated with tumor growing pattern. ER is an effective treatment to manage UGIS with favorable long-term outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical characteristics and endoscopic management of upper gastrointestinal schwannoma: 12-year experience from a large tertiary hospital in China

  • 期刊论文

  • 发表日期：

    2026年2月2日

查看全文
  • Jingyuan Xiang,
  • Longsong Li,
  • Ning Xu,
  • Shasha Wang,
  • Enqiang Linghu,
  • Ningli Chai

摘要

Background and aims

Schwannomas are rarely seen in the upper gastrointestinal tract. The diagnostic and therapeutic strategies for digestive schwannomas have not been studied comprehensively enough. We aimed to investigate the clinical and endoscopic features of upper gastrointestinal schwannomas (UGIS). Additionally, the safety and efficacy of endoscopic resection (ER) for UGIS were evaluated.

Methods

From March 2013 to June 2025, the patients who underwent ER for UGIS in our center were enrolled. Clinical characteristics, endoscopic ultrasound (EUS) and histopathological results were analyzed retrospectively. The rate of en-bloc resection, complete resection and recurrence were used to evaluate ER outcomes.

Results

In total, 54 patients (36 females, 18 males) were enrolled with a mean age of 51.6 ± 12.8 years. The mean tumor size was 21.7 mm (SD: 10.6 mm). Thirty-nine lesions were located at the gastric body, seven in the gastric antrum, two in the gastric angle and six in the esophagus. Twenty-two patients suffered from digestive symptoms including abdominal pain (11/54, 20.4%), abdominal distention (9/54, 16.7%) and acid reflux (2/54, 3.7%). The endoscopic morphology of UGIS was diverse with a predominance of hemisphere-type (32/54, 59.3%). Under EUS, most tumors presented as hypoechoic lesions (50/54, 92.6%). The rate of en-bloc and complete resection was 88.9% and no local residue or recurrence was observed during a following-up duration of 56.0 ± 39.7 months. Histopathological results revealed all tumors showed positive for S-100. For gastric schwannomas, the occurrence of digestive symptoms was more common in those tumors exhibiting extraluminal growing pattern (extraluminal vs. intraluminal = 14/23 vs. 7/25, P = 0.022).

Conclusions

UGIS demonstrates characteristic appearance under EUS. Confirmed diagnosis of UGIS depends on immunohistochemistry tests. The occurrence of clinical symptoms in gastric schwannomas might be associated with tumor growing pattern. ER is an effective treatment to manage UGIS with favorable long-term outcomes.